Search research articles
Contact Us
Filters
Showing results (621-630 of 673) with videos related to
Page
of 68
Sort By:
Transplantation and Cellular Therapy
|
June 6, 2022
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors
Nosha Farhadfar, Michael T Weaver, Zeina Al-Mansour, et al.
Science Translational Medicine
|
May 23, 2014
Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship
Irina M Shapiro, Vihren N Kolev, Christian M Vidal, et al.
Gut
|
February 14, 2006
Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease
R K Russell, H E Drummond, E R Nimmo, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 31, 2009
Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease
R K Russell, B Ip, M C Aldhous, et al.
Science Immunology
|
January 5, 2024
Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche
Jarish N Cohen, Victoire Gouirand, Courtney E Macon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 14, 2015
Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination
Kirsten S Evonuk, Brandi J Baker, Ryan E Doyle, et al.
Nature Medicine
|
July 5, 2016
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang, Samarth Hegde, Brett L Knolhoff, et al.
The Journal of Experimental Medicine
|
May 19, 2018
Bhlhe40 is an essential repressor of IL-10 during <i>Mycobacterium tuberculosis</i> infection
Jeremy P Huynh, Chih-Chung Lin, Jacqueline M Kimmey, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
IL-2-induced Stat3 Signaling is Critical for Effector Treg Cell Programming
Emma C Dean, Daniel F Ditoro, Duy Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Matthew S Davids, Bryone J Kuss, Peter Hillmen, et al.
Page
of 68
Search research articles
Search
Showing results (621-630 of 673) with videos related to
Sort By:
Page
of 68
Transplantation and Cellular Therapy
|
June 6, 2022
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors
Nosha Farhadfar, Michael T Weaver, Zeina Al-Mansour, et al.
Science Translational Medicine
|
May 23, 2014
Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship
Irina M Shapiro, Vihren N Kolev, Christian M Vidal, et al.
Gut
|
February 14, 2006
Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease
R K Russell, H E Drummond, E R Nimmo, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 31, 2009
Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease
R K Russell, B Ip, M C Aldhous, et al.
Science Immunology
|
January 5, 2024
Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche
Jarish N Cohen, Victoire Gouirand, Courtney E Macon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 14, 2015
Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination
Kirsten S Evonuk, Brandi J Baker, Ryan E Doyle, et al.
Nature Medicine
|
July 5, 2016
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Hong Jiang, Samarth Hegde, Brett L Knolhoff, et al.
The Journal of Experimental Medicine
|
May 19, 2018
Bhlhe40 is an essential repressor of IL-10 during <i>Mycobacterium tuberculosis</i> infection
Jeremy P Huynh, Chih-Chung Lin, Jacqueline M Kimmey, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
IL-2-induced Stat3 Signaling is Critical for Effector Treg Cell Programming
Emma C Dean, Daniel F Ditoro, Duy Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Matthew S Davids, Bryone J Kuss, Peter Hillmen, et al.
Page
of 68